K. Mills
Geriatrics and Gerontology · Cell Metabolism · 2007–2016
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Geriatrics and Gerontology — 17 citations into it; #51 of 114 by trust here, #59 by citations
- Molecular Biology — 10 citations into it
Whom K. Mills trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- S. Imai
- C. Cantó
- A. Berg
- R. Houtkooper
- Seon-Young Kim
- Jun Yoshino
- Nir Barzilai
- S. Shoelson
- L. Guarente
- M. Hasmann
Who trusts K. Mills overall
Papers from K. Mills's perspective
Ordered by how strongly the researchers K. Mills trusts endorse each paper. Same corpus, a different order for every researcher.
- Mitonuclear protein imbalance as a conserved longevity mechanism (Nature)
- The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* (Journal of Biological Chemistry)
- Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (Cell Metabolism)
- FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. (Cancer Research)
- NAD+ metabolism in health and disease.
- Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. (Developmental Cell)
- Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase (Nature)
- Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle (Cell Metabolism)
- Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. (Cell Metabolism)
- A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice (2016) — 803 citations
- Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (2011) — 1,291 citations
- Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (2007) — 947 citations